Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sisi He

Showing results (101-110 of 112) with videos related to

Pageof 12
Sort By:
Breast Cancer Research and Treatment|January 9, 2014
Inhibition of FGFR signaling by PD173074 improves antitumor immunity and impairs breast cancer metastasisTinghong Ye, Xiawei Wei, Tao Yin, et al.
Advanced Materials (Deerfield Beach, Fla.)|March 27, 2018
Chemical-to-Electricity Carbon: Water DeviceSisi He, Yueyu Zhang, Longbin Qiu, et al.
Nature Communications|October 13, 2017
The cholesterol metabolite 27 hydroxycholesterol facilitates breast cancer metastasis through its actions on immune cellsAmy E Baek, Yen-Rei A Yu, Sisi He, et al.
Biorxiv : the Preprint Server for Biology|September 26, 2025
LRH-1 is a novel regulator of neutrophil-driven immune responses within the tumor microenvironmentYu Wang, Bryan Duong, Sam Keeley, et al.
Nature Chemistry|January 24, 2018
Theory-driven design of high-valence metal sites for water oxidation confirmed using in situ soft X-ray absorptionXueli Zheng, Bo Zhang, Phil De Luna, et al.
Nature Chemistry|May 19, 2026
Publisher Correction: Theory-driven design of high-valence metal sites for water oxidation confirmed using in situ soft X-ray absorptionXueli Zheng, Bo Zhang, Phil De Luna, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|August 6, 2022
The nuclear receptor TLX (NR2E1) inhibits growth and progression of triple- negative breast cancerAdam T Nelczyk, Liqian Ma, Anasuya Das Gupta, et al.
Cancer Letters|June 22, 2024
NR0B2 re-educates myeloid immune cells to reduce regulatory T cell expansion and progression of breast and other solid tumorsHashni Epa Vidana Gamage, Sayyed Hamed Shahoei, Yu Wang, et al.
Cancer Letters|June 29, 2024
Development of NR0B2 as a therapeutic target for the re-education of tumor associated myeloid cellsHashni Epa Vidana Gamage, Samuel T Albright, Amanda J Smith, et al.
Biorxiv : the Preprint Server for Biology|August 30, 2023
Re-education of myeloid immune cells to reduce regulatory T cell expansion and impede breast cancer progressionHashni Epa Vidana Gamage, Sayyed Hamed Shahoei, Samuel T Albright, et al.
Pageof 12

Showing results (101-110 of 112) with videos related to

Sort By:
Pageof 12
Breast Cancer Research and Treatment|January 9, 2014
Inhibition of FGFR signaling by PD173074 improves antitumor immunity and impairs breast cancer metastasisTinghong Ye, Xiawei Wei, Tao Yin, et al.
Advanced Materials (Deerfield Beach, Fla.)|March 27, 2018
Chemical-to-Electricity Carbon: Water DeviceSisi He, Yueyu Zhang, Longbin Qiu, et al.
Nature Communications|October 13, 2017
The cholesterol metabolite 27 hydroxycholesterol facilitates breast cancer metastasis through its actions on immune cellsAmy E Baek, Yen-Rei A Yu, Sisi He, et al.
Biorxiv : the Preprint Server for Biology|September 26, 2025
LRH-1 is a novel regulator of neutrophil-driven immune responses within the tumor microenvironmentYu Wang, Bryan Duong, Sam Keeley, et al.
Nature Chemistry|January 24, 2018
Theory-driven design of high-valence metal sites for water oxidation confirmed using in situ soft X-ray absorptionXueli Zheng, Bo Zhang, Phil De Luna, et al.
Nature Chemistry|May 19, 2026
Publisher Correction: Theory-driven design of high-valence metal sites for water oxidation confirmed using in situ soft X-ray absorptionXueli Zheng, Bo Zhang, Phil De Luna, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|August 6, 2022
The nuclear receptor TLX (NR2E1) inhibits growth and progression of triple- negative breast cancerAdam T Nelczyk, Liqian Ma, Anasuya Das Gupta, et al.
Cancer Letters|June 22, 2024
NR0B2 re-educates myeloid immune cells to reduce regulatory T cell expansion and progression of breast and other solid tumorsHashni Epa Vidana Gamage, Sayyed Hamed Shahoei, Yu Wang, et al.
Cancer Letters|June 29, 2024
Development of NR0B2 as a therapeutic target for the re-education of tumor associated myeloid cellsHashni Epa Vidana Gamage, Samuel T Albright, Amanda J Smith, et al.
Biorxiv : the Preprint Server for Biology|August 30, 2023
Re-education of myeloid immune cells to reduce regulatory T cell expansion and impede breast cancer progressionHashni Epa Vidana Gamage, Sayyed Hamed Shahoei, Samuel T Albright, et al.
Pageof 12